Login
$STOK
$26.13 +$0.67 (2.63%) Close

Company Executives

$STOK Management Team

Dr. Arthur Tzianabos

Independent Chairman of the Board

Age 62
Compensation $150.6K USD
Sex Male

Mr. Thomas Leggett

Chief Financial Officer

Age 48
Compensation $4.520M USD
Sex Male

Mr. Ian Smith

Chief Executive Officer

Principal Executive Officer

Director

Age 59
Compensation $248.3K USD
Sex Male

Mr. Jonathan Allan

General Counsel

Corporate Secretary

Age 35
Compensation -
Sex Male

Dr. Barry Ticho

Chief Medical Officer

Age 65
Compensation $2.469M USD
Sex Male

Mr. Eric Rojas

Vice President and Head of Investor Relations

Age -
Compensation -
Sex Male
Directors
9
serving now
Independent
Not stated
the proxy does not say
Average tenure
7.6 years
from year joined
CEO also chairs the board
No
Arthur O. Tzianabos
Director Age On board Independent Committees Other public boards 2025 pay Source
G. Clare Kahn
74 2026
0 years
Not stated
Research and Development Committee · Chair
None stated Not stated
Adrian R. Krainer
67 2014
12 years
Not stated
Nominating and Corporate Governance Committee
None stated Not stated
Julie Anne Smith
55 Not stated Not stated
Audit Committee
Exelixis, Inc. $283,338
Jennifer C. Burstein
54 2019
7 years
Not stated
Audit Committee · Chair
None stated Not stated
Arthur A. Levin
72 2015
11 years
Not stated
Nominating and Corporate Governance Committee · Chair
Avidity Biosciences, Inc. Not stated
Ian F. Smith
60 2023
3 years
Not stated None stated None stated Paid as CEO
Edward M. Kaye
76 2017
9 years
Not stated
Research and Development Committee
Cytokinetics, Inc., Avidity Biosciences, Inc. Not stated
Seth L. Harrison
65 2015
11 years
Not stated
Compensation Committee
None stated $270,838
Arthur O. Tzianabos
63 2018
8 years
Not stated
Compensation Committee · Chair
None stated Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 22, 2026 states there were none.

Read it in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support